Retevmo
FDA Approves FoundationOne CDx for Eli Lilly's Retevmo
The tissue-based test can determine if Retevmo is an appropriate treatment for patients with RET gene fusions.
The tissue-based test can determine if Retevmo is an appropriate treatment for patients with RET gene fusions.